Navigation Links
LifeVantage to Present at Rodman & Renshaw Annual Global Investment Conference
Date:8/31/2011

SALT LAKE CITY, Aug. 31, 2011 /PRNewswire/ -- LifeVantage Corporation (OTCBB: LFVN), makers of Protandim®, the Nrf2 Synergizer™ patented dietary supplement, announced today that Douglas C. Robinson, the Company's President and Chief Executive Officer, and Dr. Joe McCord, the Company's Chief Science Officer, will be presenting at the Rodman & Renshaw Annual Global Investment Conference, to be held on September 11-13, 2011, at the Waldorf Astoria in New York.

(Logo: http://photos.prnewswire.com/prnh/20090930/LIFEVANTAGELOGO)  

The LifeVantage investor presentation is scheduled for Tuesday, September 13, 2011, at 9:10 am Eastern Time.  The presentation will be webcast live and archived at www.LifeVantage.com. Visitors to the website should select the "Investor Info" link to access the webcast.

At the Rodman & Renshaw Annual Global Investment Conference, more than 520 public & private companies from around the world are registered to present in front of an audience of over 4,000 attendees. The conference will feature tracks devoted to Healthcare, China, Metals & Mining, Energy, Technology, Cleantech, Financial Services, Israel and Growth/Special Situations. Al Gore, 45th Vice President of the United States, will open the Conference as the Keynote Speaker on Monday, September 12, 2011. Additional highlights of the conference include a speech by Henry Kissinger, 56th United States Secretary of State, who will address the audience as a special Guest Speaker on Tuesday, September 13, 2011. Dr. Kissinger's speech will be followed by corporate presentations, Q & A sessions, investor one-on-one meetings and daily networking opportunities.

About LifeVantage Corporation

LifeVantage, (OTCBB: LFVN), makers of Protandim®, the Nrf2 Synergizer™ patented dietary supplement, is a science based nutraceutical company. LifeVantage is dedicated to visionary science that promises to transform wellness and anti-aging internally and externally with supplements that dramatically reduce oxidative stress at the cellular level. The Company was founded in 2003 and currently has operations in Salt Lake City, Utah and San Diego, CA. For more information, visit www.LifeVantage.com.

Investor Relations Contact:
Cindy England (801) 432-9036
Director of Investor Relations
-or-
John Mills (310) 954-1105
Senior Managing Director, ICR, LLC


'/>"/>
SOURCE LifeVantage Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. LifeVantage Announces Preliminary Third Quarter 2011 Revenue
2. LifeVantage Announces Settlement of Zrii Litigation
3. LifeVantage Announces Unaudited First Quarter Fiscal 2010 Financial and Operating Results
4. LifeVantage Announces Preliminary Unaudited First Quarter Revenue
5. LifeVantage Announces Fourth Quarter and Fiscal Year 2009 Financial and Operating Results
6. Echo Therapeutics to Present at the Stifel Nicolaus Healthcare Conference 2011
7. BioDelivery Sciences Announces Upcoming Presentations at Three Investor Conferences
8. Elbit Imaging Announces Availability of Investor Relations Presentation - Analysis Sources and Uses
9. Inovio Pharmaceuticals to Present at Investor Conferences
10. Watson to Present at the 2011 Morgan Stanley Global Healthcare Conference
11. Luminex Corporation to Present at Upcoming Investment Conferences In September
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/2/2017)... , Aug. 2, 2017  Life Flight Network and PeaceHealth ... agreement improves patient care and operational efficiency for patients at ... , Cottage Grove , and ... transportation. PeaceHealth and Life Flight Network work collaboratively to move ... transport, or when a time sensitive emergency exists. ...
(Date:8/1/2017)... 1, 2017   CerSci Therapeutics , a non-opioid ... , has received notice from the National Institute ... Health (NIH) that it has been awarded a Direct-to-Phase ... $650,000 in 2017 with an additional $1,000,000 to follow ... Drug application of their lead non-opioid drug candidate CT-044 ...
(Date:7/31/2017)... Tru-D SmartUVC robots have arrived at Brian Allgood Army Community ... for "Total Room Ultraviolet Disinfection," is a 5-foot-5 germ-killing robot that is ... cleans the area with traditional cleaning protocols. ... Tru-D fights germs at Army hospitals ... "Although the BAACH has a very low infection rate, below national ...
Breaking Medicine Technology:
(Date:8/24/2017)... ... , ... There is no doubt in anyone’s mind that NoSQL databases scale out to large ... the ability to scale to a 1000 nodes, Gensonix can scale to 100,000 nodes without ... Big Data loads. , First of all, Gensonix stands as the only DB (SQL or ...
(Date:8/24/2017)... Fredericton, NB (PRWEB) , ... August 24, 2017 , ... ... culmination of 18 years of contact center application development experience. It represents ... modern contact center. , Indosoft designed Q-Suite NG for simple integration. A full ...
(Date:8/23/2017)... , ... August 23, 2017 , ... The Arc Mercer, ... disabilities (I/DD), has launched a groundbreaking LGBTQ community organization for people with special needs. ... organization of its kind in the state of New Jersey – but the first ...
(Date:8/23/2017)... , ... August 23, 2017 , ... ... Vice President Business Development and Sector Growth. Mr. Smith joins other recent high-profile ... , Mr. Smith’s healthcare career began in 1993, helping physician practices and ...
(Date:8/23/2017)... ... August 23, 2017 , ... Based on worldwide research and ... of HBOT in treating and helping to heal addictions and substance abuse disorders. ... similarities of the wounds to the brain from traumatic brain injuries, and the ...
Breaking Medicine News(10 mins):